DaisukeKotani· @DaisukeKotani · X·· 5 天前评分60
正文 · 原文
#ESMO26 | 2875O KEYNOTE-975 Pembro or placebo + dCRT in esophageal cancer - EFS: HR 0.97 (CPS ≥10) - OS: HR 1.00 (CPS ≥10) @myESMO @OncoAlert https://t.co/APlJnQ7Fnh
热度 26 · 17 赞 · 0 回复 · 9 转发
会议摘要
NCT04210115NCT04210115按 - **标题 / Title：** Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975) 对上
- **标题 / Title：** Study of Pembrolizumab (MK-3475) Versus Placebo in Participants With Esophageal Carcinoma Who Are Receiving Chemotherapy and Radiation Therapy (MK-3475-975/KEYNOTE-975)读摘要原文 →来源：DaisukeKotani · x.com